LYMPHOMA RECEIVING CAR-T THERAPY
Clinical trials for LYMPHOMA RECEIVING CAR-T THERAPY explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA RECEIVING CAR-T THERAPY trials appear
Sign up with your email to follow new studies for LYMPHOMA RECEIVING CAR-T THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Off-the-Shelf CAR-T therapy offers new hope for tough blood cancers
Disease control Recruiting nowThis study tests a new CAR-T therapy called Allo-QuadCAR01-T for people with B-cell cancers that have not responded to other treatments. Unlike current therapies that use a patient's own cells, this one uses donor cells that are ready to use, saving time and reducing cost. It tar…
Matched conditions: LYMPHOMA RECEIVING CAR-T THERAPY
Phase: PHASE1, PHASE2 • Sponsor: AvenCell Therapeutics, Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
CAR-T Therapy's hidden brain impact under the microscope
Knowledge-focused Recruiting nowThis study looks at how CAR-T cell therapy for lymphoma might affect memory, concentration, and brain structure. Researchers will follow 120 adults before and after treatment using thinking tests and brain scans. The goal is to understand these changes, not to test a new treatmen…
Matched conditions: LYMPHOMA RECEIVING CAR-T THERAPY
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 08:03 UTC